Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,152 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05593081Recruiting
Study of sudden type 1 diabetes after rapid symptom onset
This trial studies people who develop severe, fast-onset “type 1 diabetes” with body-wide stress (ketosis/ketoacidosis) soon after symptoms start. It aims to better understand this condition and how to care for it early.
Quanzhou, FujianAges Any age - NCT05363761RecruitingPhase 1
Artery procedure to treat type 2 diabetes and related problems
This Phase 1 study tests a new artery “ablation” procedure for people with type 2 diabetes, aiming to improve diabetes and related conditions like high blood pressure. It will also check whether the procedure is safe and works well enough to study further.
Panama CityAges 21–65 - NCT05369065RecruitingPhase 1
Artery ablation for type 2 diabetes with kidney and liver arteries
This Phase 1 study tests whether a minimally invasive artery procedure can improve type 2 diabetes and related health problems by targeting kidney and liver blood vessels. Because it’s early-stage, the main goal is safety and learning how the treatment works in people who meet specific diabetes, blood pressure, and blood test requirements.
TbilisiAges 21–65 - NCT05697991Recruiting
Study of fatty liver in adults with type 2 diabetes
This study looks at people with type 2 diabetes who also have fatty liver. The goal is to learn more about this condition in a Saudi group and test approaches that could improve care.
Riyadh, Select A State Or ProvinceAges 18–60 - NCT04993482Recruiting
Tracks daily movement habits in adults with type 2 diabetes
This study looks at your usual 24-hour movement pattern (like being active, sitting, and sleeping). It may help researchers better understand daily behavior patterns in people with type 2 diabetes.
GhentAges 18–100 - NCT05801614Recruiting
Tested diet to help control glucose in early type 2 diabetes
This study tests whether carbohydrate or calorie restriction can help normalize blood sugar levels in people with relatively early type 2 diabetes. It may help those whose diabetes control is not yet fully under control but who do not have major recent heart problems.
StockholmAges 24–70 - NCT04011020RecruitingPhase 3
Stem cell treatment for type 1 diabetes
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
Paramus, New JerseyAges 10 years+ - NCT07852988RecruitingPhase 4
Adding digestive enzymes to usual diabetes treatment
This study tests adding a digestive enzyme (pancreatin) to your usual diabetes medicines to see if it helps control blood sugar better. You may benefit if your current treatment is working, but your A1C is still not in the target range.
Zabrze, Silesian VoivodeshipAges 35–75 - NCT07843485RecruitingPhase 3
Weight loss medication for adults with type 2 diabetes
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
Los Angeles, CaliforniaAges 18 years+ - NCT07835724Recruiting
Understanding what causes type 1 diabetes
This study looks at how things in the environment might affect the risk of type 1 diabetes. It aims to find out what triggers the disease, which could help with prevention and treatment.
Changsha, HunanAges 3–70 - NCT07835360Recruiting
Body changes after starting GLP-1 medications for weight or diabetes
This study looks at how your body composition (muscle and fat) changes after you start a GLP-1 medication for obesity or type 2 diabetes. You will be followed for a year with body scans to see the effects.
Mexico City, Mexico CityAges 18 years+ - NCT07837934RecruitingPhase 2
Colchicine to prevent heart disease in adults with type 2 diabetes
This trial tests whether a daily low-dose of colchicine, a common anti-inflammatory medicine, can help prevent heart attacks and strokes in people with type 2 diabetes who do not yet have heart disease. If it works, it could be a simple addition to your current diabetes care.
Singapore, SingaporeAges 21–80 - NCT07831798RecruitingPhase 1/Phase 2
Gene therapy for type 1 diabetes
This study tests a new gene therapy (VV-14300) that aims to help people with type 1 diabetes make insulin again. It might improve blood sugar control and reduce the need for insulin.
TorontoAges 18–65 - NCT07829302RecruitingPhase 1/Phase 2
Gene therapy for type 1 diabetes
This trial tests an investigational gene therapy that may help people with type 1 diabetes produce some insulin on their own, potentially reducing the amount of insulin they need. It is an early-stage study, so participants will be closely monitored for safety and any changes in their diabetes control.
MelbourneAges 18–65 - NCT07827625Recruiting
Comparing two physical therapies for ankle pain in type 2 diabetes
This study tests whether a specific hands-on therapy (Mulligan mobilization) improves ankle motion, pain, and quality of life better than standard physical therapy in people with type 2 diabetes who have ankle stiffness and pain.
Islamabad, FederalAges 50–70 - NCT07817251RecruitingPhase 3
Switching From Semaglutide to Cagrisema in Type 2 Diabetes
This study looks at how people with type 2 diabetes tolerate switching from a weekly semaglutide injection (like Ozempic or Wegovy) to a new experimental medicine called Cagrisema. The goal is to see if the switch is safe and effective.
Gilbert, ArizonaAges 18 years+ - NCT06513247Recruiting
Screening for type 1 diabetes in high-risk relatives
This study screens high-risk children for early signs of type 1 diabetes by testing relatives who already have the condition. It aims to catch diabetes early so treatment can start sooner.
RiyadhAges 2–18 - NCT07786194Recruiting
Balance training for older adults with type 2 diabetes
This study tests a balance training program to see if it improves balance and body awareness in people with type 2 diabetes who are 60 or older. It may help you move better and prevent falls.
Edegem, AntwerpenAges 60 years+ - NCT07790081Recruiting
Adding videos to food bank nutrition classes to lower diabetes risk
This study tests whether adding educational videos to Seva Food Bank's cooking and nutrition classes helps people lower their risk of developing type 2 diabetes. If you join one of these programs, you might learn helpful tips to make healthier food choices.
Mississauga, OntarioAges 16 years+ - NCT07784270RecruitingPhase 3
Weight loss injection for adults with type 2 diabetes and overweight
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Fairhope, AlabamaAges 18 years+ - NCT07776509RecruitingPhase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Escondido, CaliforniaAges 18 years+ - NCT07767331Recruiting
Patient-reported outcomes for type 2 diabetes
This trial asks people with type 2 diabetes to fill out a questionnaire about their health and daily life. The answers help doctors in general practice provide better care.
AarhusAges 18 years+ - NCT07770204Recruiting
Music during surgery for people with type 2 diabetes
This study tests whether listening to calming music before and during surgery can help reduce stress and improve recovery for people with type 2 diabetes. If you are scheduled for elective surgery and have type 2 diabetes, you may be able to join.
Istanbul, IstanbulAges 40–70 - NCT07771010RecruitingPhase 4
Comparing empagliflozin and metformin for muscle health in type 2 diabetes
This study tests two diabetes medications, empagliflozin and metformin, to see how they affect muscle energy use and blood flow in men with recently diagnosed type 2 diabetes. Participants will be followed at a diabetes clinic.
LjubljanaAges 18–75
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,152 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.